A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Dengue viruses (DENV) infect 50 to 100 million people worldwide per year, of which 500,000 develop severe life-threatening disease. This mosquito-borne illness is endemic in most tropical and subtropical countries and has spread significantly over the last decade. While there are several promising v...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Byrd, Chelsea M., Dai, Dongcheng, Grosenbach, Douglas W., Berhanu, Aklile, Jones, Kevin F., Cardwell, Kara B., Schneider, Christine, Wineinger, Kristin A., Page, Jessica M., Harver, Chris, Stavale, Eric, Tyavanagimatt, Shanthakumar, Stone, Melialani A., Bartenschlager, Ralf, Scaturro, Pietro, Hruby, Dennis E., Jordan, Robert
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2013
Teme:
Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535982/
https://ncbi.nlm.nih.gov/pubmed/23070172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01429-12
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items